Enhanced Outcomes with Combined Intrahepatic and Periduodenal Lymphatic Embolization in Congenital Heart Disease-associated Protein-Losing Enteropathy

Enhanced Outcomes with Combined Intrahepatic and Periduodenal Lymphatic Embolization in Congenital Heart Disease-associated Protein-Losing Enteropathy

Combined intrahepatic and periduodenal lymphatic embolization significantly improves protein balance and remission duration in congenital heart disease patients with protein-losing enteropathy compared to intrahepatic embolization alone, offering a promising targeted interventional strategy.